Mubashir Billah, MD
Urology · Millburn, NJNPI 1235587478
Payments from drug & device makers
Across 115 payments — averaging $129.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$7K
- EDAP Technomed Inc$2K
- Boston Scientific$2K
- Procept Biorobotics Corporation$1K
- Johnson & Johnson$603
- Kerecis Limited$494
- plus $2K from 25 others
What the payments were for
- Travel & lodging$3,09521%
- Food & beverage$7,54851%
- Education$4,26529%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 12 | $6,696 |
| EDAP Technomed Inc | 8 | $2,006 |
| Boston Scientific | 22 | $1,666 |
| Procept Biorobotics Corporation | 12 | $1,425 |
| Johnson & Johnson(2 entities) | 7 | $603 |
| Kerecis Limited | 2 | $494 |
| Astellas Pharma US Inc | 5 | $294 |
| Stryker | 1 | $285 |
| Axonics, Inc. | 2 | $148 |
| Bayer | 2 | $141 |
| Coloplast | 1 | $136 |
| Sumitomo Pharma America, Inc. | 1 | $120 |
| Tolmar, Inc. | 7 | $113 |
| Clarus Therapeutics Inc. | 1 | $110 |
| Endo Pharmaceuticals Inc. | 1 | $106 |
| Urogen Pharma, Inc. | 5 | $84 |
| Olympus America Inc. | 3 | $57 |
| Laborie Medical Technologies Corp. | 1 | $49 |
| AstraZeneca | 3 | $47 |
| Pfizer | 3 | $47 |
| Ferring Pharmaceuticals Inc. | 2 | $43 |
| Myovant Sciences Inc. | 3 | $43 |
| Tolmar Pharmaceuticals, Inc. | 2 | $31 |
| Janssen Scientific Affairs, LLC | 1 | $31 |
| Urovant Sciences Inc | 2 | $28 |
| Profound Medical Corp. | 1 | $22 |
| SRS Medical Systems, Inc. | 1 | $21 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
| Tempus AI, Inc | 1 | $15 |
| Azurity Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$6,615
- Kerecis SurgiClose$1,974
- AMS 700$988
- AquaBeam Robotic System$830
- AQUABEAM SYSTEM$526
- Kerecis GraftGuide$494
- STRATAFIX$436
- JATENZO$329
- Echelon Flex$319
- SCOPIS ENT$285
- SURGICEL NU-KNIT$154
- ALTIS$136
- GENERAL ERECTILE DYSFUNCTION$132
- Axonics$130
- Bulkamid$130
- Nubeqa$125
- ECHELON ENDOPATH$125
- DERMABOND PRINEO$125
- GEMTESA$120
- VISTASEAL$117
How this compares
$14,908 in reported general payments places this provider in the 80th percentile of 401 urology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 239 | $210,054 |
| GemtesaVibegron | 62 | $64,417 |
| Tamsulosin Hcl | 656 | $14,483 |
| Mirabegron ErMirabegron | 13 | $9,985 |
| Potassium Citrate ErPotassium Citrate | 89 | $6,293 |
| Silodosin | 39 | $4,478 |
| Finasteride | 189 | $3,306 |
| Oxybutynin Chloride ErOxybutynin Chloride | 85 | $2,506 |
| Estradiol | 28 | $1,617 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 32 | $763 |
| Solifenacin Succinate | 22 | $711 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 37 | $676 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 149 | $559 |
| Ciprofloxacin Hcl | 78 | $502 |
| Oxybutynin Chloride | 19 | $481 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $294 | $210,054239 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $120 | $64,41762 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 401 urology providers in New Jersey.
Other urology in Millburn
- Stuart ShoengoldMillburn$96K
- Gordon BrownCherry Hill$2.8M
- Nitin YerramHackensack$1.6M
- Michael StifelmanHackensack$1.5M
- Thomas MuellerLinwood$1.2M
- David SussmanLinwood$833K
- Michael IngberDenville$607K
- Ravi MunverHackensack$529K
- Grannum SantBridgewater$487K
- Mutahar AhmedMaywood$464K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.